Zami Aberman, CEO & Chairman at PLURISTEM THERAPEUTICS INC (PSTI), bought 13,000 shares at $2.65 ($34K) on 2014-11-11, disclosed to the SEC on 2014-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.62 | 6,500 | $17K | 49.7% |
| 2 | $2.65 | 6,500 | $17K | 50.3% |
| Total | $2.63 avg | 13,000 | $34K | 100% |
| Filing → |
| PSTI | BUY | 2019-04-08 | $100K | — | Filing → |
| PSTI | BUY | 2016-02-24 | $7K | — | Filing → |
| PSTI | BUY | 2016-02-17 | $16K | — | Filing → |